Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (EKSO)
NASDAQ:EKSO
Earnings Data
Report Date
Apr 24, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.11Last Year’s EPS
-0.2Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 03, 2025
|% Change Since: 0.00%
|Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative trends. While there were record-breaking quarterly revenues, improved margins, and strategic partnerships, there were also challenges such as a decline in full-year revenue and increased net loss for the quarter. The company's strategic efforts to enhance market access and reimbursement processes indicate optimism for future growth.Company Guidance
During Ekso Bionics Holdings, Inc.'s Fourth Quarter 2024 Financial Results Conference Call, the company provided guidance on several key metrics and strategic initiatives. For Q4 2024, Ekso Bionics reported a revenue of $5.1 million, marking a 5% increase from the $4.8 million reported in the same period of 2023. The gross profit stood at $2.7 million, reflecting a gross margin of 53%, up from 49% in the previous year. Operating expenses decreased by 15% to $4.9 million, leading to a net loss of $3.4 million or $0.14 per share. For the full year 2024, revenue was slightly down at $17.9 million compared to $18.3 million in 2023, with gross profit rising to $9.5 million and a gross margin of 53%. Operating expenses for the year decreased by 17% to $20 million, resulting in a net loss of $11.3 million or $0.56 per share. The company emphasized its strategic focus on expanding market access for its Ekso Indigo Personal device, leveraging the newly established CMS reimbursement framework, and partnerships with Priya Healthcare and National Seating and Mobility. Ekso Bionics anticipates increased contributions from its personal health products in 2025, driven by efforts to submit claims to CMS for eligible Medicare beneficiaries.Record-Breaking Quarterly Revenue
The company recorded revenue of $5.1 million in the fourth quarter of 2024, an increase of 5% compared to $4.8 million in the same period in 2023.
Improved Gross Margin
Gross margin increased to approximately 53% in Q4 2024, compared to 49% in Q4 2023, due to supply chain improvements and reduced service costs.
Decreased Operating Expenses
Operating expenses for Q4 2024 were $4.9 million, a 15% decrease compared to $5.8 million for Q4 2023, primarily due to a decrease in headcount and discretionary payroll.
Positive Gross Margin Trend
For the full year 2024, gross profit was $9.5 million, with a gross margin of 53%, compared to a gross margin of 50% in 2023.
Successful CMS Pricing Determination
CMS established pricing determination for the Ekso Indigo Personal device in Q2 2024, creating a significant opportunity to help Medicare enrollees living with spinal cord injuries.
Engagement with Priya Healthcare
Engaged Priya Healthcare to help navigate the complexities of CMS reimbursement, enhancing the ability to submit Medicare claims.
Exclusive Distribution with National Seating and Mobility
Ekso Bionics partnered with National Seating and Mobility as the exclusive distributor within the CRT industry in the United States, expanding access to Ekso Indigo Personal.
---
EKSO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EKSO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 03, 2025 | $0.48 | $0.48 | 0.00% |
| Oct 28, 2024 | $1.13 | $0.96 | -15.04% |
| Jul 29, 2024 | $1.48 | $1.06 | -28.38% |
| Apr 29, 2024 | $1.29 | $1.24 | -3.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does EKSO BIONICS (EKSO) report earnings?
EKSO BIONICS (EKSO) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
What is EKSO BIONICS (EKSO) earnings time?
EKSO BIONICS (EKSO) earnings time is at Apr 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EKSO EPS forecast?
EKSO EPS forecast for the fiscal quarter 2025 (Q1) is -0.11.
---